The9 Ltd
NCTY
Bit Digital
BTBT
TeraWulf
WULF
4
Digihost Technology
DGHI
5
BTCS Inc
BTCS
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.